Peripheral Blood Flow Responses to Electromagnetic Energy
ConditionExposure to Man-made Visible Light
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-59
SponsorUniversity of Alabama at Birmingham
About this trial
This study evaluates 670 nm energy in the form of red light to stimulate blood flow changes in healthy adults. All participants will receive red light to their leg. They will also receive a continuous infusion of Definity (octafluoropropane) ultrasound contrast.
Eligibility criteria
Qualifiers
Participants will be healthy subjects over the age of 18.
Men and women will be recruited for participation.
All ethnicities will be included in this study.
Disqualifiers
age under 18 years and those over 60 years of age,
those who are unable to understand the consent process,
those who cannot read or speak English,
a history of cancer,
Trial design
Treatments tested in this trial
- 670 nm light
- octafluropropane
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov